These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1775978)

  • 1. Future potential of adjuvant and neoadjuvant therapy.
    Yarbro JW
    Semin Oncol; 1991 Dec; 18(6):613-9. PubMed ID: 1775978
    [No Abstract]   [Full Text] [Related]  

  • 2. Theoretical considerations regarding the early use of adjuvant chemotherapy.
    Goldie JH; Coldman AJ
    Recent Results Cancer Res; 1986; 103():30-5. PubMed ID: 3738195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Present and future of research in the diagnosis and treatment of cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990 Jun; 43(5):463-78. PubMed ID: 2202263
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple drug resistance in cancer therapy.
    Schneider E; Cowan KH
    Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for invasive bladder cancer: future directions.
    Scher HI; Splinter TA
    Semin Oncol; 1990 Oct; 17(5):635-8. PubMed ID: 2218577
    [No Abstract]   [Full Text] [Related]  

  • 6. Concepts for the treatment of tumor metastasis.
    Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR
    Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
    Larsson R; Nygren P; Bergh J
    Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug resistance.
    Moscow JA; Cowan KH
    Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
    [No Abstract]   [Full Text] [Related]  

  • 9. The multidrug resistance phenotype in human cancer.
    Cordon-Cardo C; O'Brien JP
    Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
    Ellis A; Lishner M; Manor J; Ravid M
    Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
    González-Manzano R
    Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
    DeMichele A; Yee D; Esserman L
    N Engl J Med; 2017 Dec; 377(23):2287-2289. PubMed ID: 29211674
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant and neoadjuvant therapy for gastric cancer.
    Gonzalez RJ; Mansfield PF
    Surg Clin North Am; 2005 Oct; 85(5):1033-51, viii. PubMed ID: 16139035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of tumoral resistance to antineoplastic agents].
    Albiero AL; Pozzi DH
    Rev Assoc Med Bras (1992); 1994; 40(2):125-8. PubMed ID: 7820150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles of adjuvant cytostatic therapy].
    Schreml W
    Aktuelle Probl Chir Orthop; 1982; 22():10-7. PubMed ID: 6121507
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental basis of adjuvant chemotherapy.
    Sakurai Y
    Prog Clin Biol Res; 1983; 132E():3-10. PubMed ID: 6647472
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents.
    Milas L; Tofilon PJ; Brock WA
    Prog Clin Biol Res; 1986; 212():305-21. PubMed ID: 3520579
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer therapeutics: personal experiences and future perspectives.
    Mihich E
    Cancer Biol Ther; 2004 Sep; 3(9):911-5. PubMed ID: 15326391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs].
    Possinger K; Hartenstein R; Ehrhart H
    MMW Munch Med Wochenschr; 1978 May; 120(21):725-8. PubMed ID: 306551
    [No Abstract]   [Full Text] [Related]  

  • 20. Thoughts on cancer chemotherapy and combination modality therapy (1974).
    Skipper HE
    JAMA; 1974 Nov; 230(7):1033-5. PubMed ID: 4608173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.